Desktop Health Announces First Patients Treated with FDA-Cleared CMFlex™ – an Off-the-Shelf 3D Printed Synthetic Bone Graft Product Pioneered by Dimension Inx on the 3D-Bioplotter®
Desktop Health – the trusted production-grade medical 3D printing brand of Desktop Metal, Inc. (NYSE: DM) – today announced the first patients have been treated with CMFlex™, an off-the-shelf 3D printed synthetic bone graft product developed and manufactured by Chicago-based Dimension Inx on the 3D-Bioplotter®.
- Desktop Health – the trusted production-grade medical 3D printing brand of Desktop Metal, Inc. (NYSE: DM) – today announced the first patients have been treated with CMFlex™, an off-the-shelf 3D printed synthetic bone graft product developed and manufactured by Chicago-based Dimension Inx on the 3D-Bioplotter®.
- The duo have been developing the material and product since 2009 on the Desktop Health 3D-Bioplotter®.
- (Photo: Business Wire)
Founded in 2017, Dimension Inx is a regenerative therapeutics company that designs, develops, and manufactures therapeutic products to restore tissue and organ function. - The company owns four Desktop Health 3D-Bioplotters – two used for R&D and two used for manufacturing their commercial CMFlex product.